Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy

Overview of attention for article published in Journal of Translational Medicine, March 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 1 X post from an account with 1,147 followers.

Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy http://t.co/WdrX4Q8prA

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.